Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fagron N.V. Board/Management Information 2019

Dec 20, 2019

3949_iss_2019-12-20_8c95f526-91d1-49c2-b5bb-8a03353fa6d0.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 December 2019

Rob ten Hoedt non-executive director of Fagron

The Board of Directors of Fagron has decided, following the advice of the nomination and remuneration committee, to co-opt Rob ten Hoedt as non-executive and independent director of Fagron.

Koen Hoffman, chairman of the Board of Directors: "We are pleased to welcome Rob ten Hoedt on the Board of Directors. With his broad and international management experience and extensive background in the medical technology industry, he will be a valuable addition to our Board."

The appointment of Mr. Ten Hoedt is subject to approval by the next general meeting of shareholders of Fagron.

Rob ten Hoedt (1960)

Rob ten Hoedt is President for Europe, the Middle East and Africa (EMEA) and member of the Executive Committee of Medtronic (www.medtronic.com). Ten Hoedt has held numerous international sales, marketing and general management positions in the medical technology industry and has been with Medtronic since 1991. He is also chairman of the board of Medtech Europe, the European trade association for the medical technology industry. Ten Hoedt, who has Dutch nationality, obtained a bachelor's degree in commercial economics at the HEAO school for higher education and a master's degree in marketing from the Netherlands Institute of Marketing (NIMA).

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For further information Constantijn van Rietschoten Chief Communications Officer Tel. +31 6 53 69 15 85 [email protected]